Phase I study of BAY 94-9027, a PEGylated B-domain-deleted recombinant factor VIII with an extended half-life, in subjects with hemophilia A

BACKGROUND: BAY 94-9027 is a B-domain-deleted recombinant factor VIII (rFVIII) with site-specific attachment of poly(ethylene glycol) that has shown an extended half-life in animal models of hemophilia. OBJECTIVES: To assess the pharmacokinetics and safety of BAY 94-9027 after single and repeated ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Coyle, T E, Reding, M T, Lin, J C, Michaels, L A, Shah, A, Powell, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Clinical Haemostasis and Thrombosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265842/
https://www.ncbi.nlm.nih.gov/pubmed/24843882
http://dx.doi.org/10.1111/jth.12506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265842/
https://www.ncbi.nlm.nih.gov/pubmed/24843882
http://dx.doi.org/10.1111/jth.12506

Ejemplares similares